The contrasting data about IL-33 levels in patient serum could be both correlated to the rather short half-life of the molecule or to the fact that in some kinds of tumors it is secreted nearby its niche of near the neoplastic mass (i.e., lung cancer). The gene discussed is IL33; the disease is lung carcinoma.